TickerFacts.

Niagen Bioscience, Inc. (NAGE): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$21.18M
Year ended 2019-12-31
2011-01-01: -$2.83M2011-12-31: -$4.25M2012-12-29: -$10.14M2013-12-28: -$4.04M2015-01-03: -$2.70M2016-01-02: -$2.64M2016-12-31: -$4.44M2017-12-30: -$10.97M2018-12-31: -$22.23M2019-12-31: -$21.18M-$21.18M
2011-01-01 Free Cash Flow (USD) 2019-12-31
Period endedFree Cash FlowChange YoYSource filing
2019-12-31-$21.18Mn/m2021-03-12, From 2019-01-01
2018-12-31-$22.23Mn/m2020-03-10, From 2017-12-31
2017-12-30-$10.97Mn/m2019-03-07, From 2017-01-01
2016-12-31-$4.44Mn/m2018-03-15, From 2016-01-03
2016-01-02, Fiscal 2015-$2.64Mn/m2018-03-15, From 2015-01-04
2015-01-03, Fiscal 2014-$2.70Mn/m2017-03-16, From 2013-12-29
2013-12-28-$4.04Mn/m2016-03-17, From 2012-12-30
2012-12-29-$10.14Mn/m2014-03-27, From 2012-01-01
2011-12-31-$4.25Mn/m2013-03-29, From 2011-01-02
2011-01-01, Fiscal 2010-$2.83Mn/a2012-03-15, From 2010-01-03